Breaking newsEAN NewsCOVID-19ResearchTop Articles
Remdesivir for the treatment of Covid-19 — preliminary report
In this article, just published in the New England Journal of Medicine, Beigel et al. conducted a double-blind, randomised, placebo-controlled trial of intravenous remdesivir in adults hospitalised with Covid-19 with evidence of lower respiratory tract involvement.










The 6th Annual Congress of the European Academy of Neurology and first Virtual Congress was a record-breaking event, with more than 42,502 registered participants. This makes it the biggest neurology event in history!
With more than 5,233 days of combined…